Taken together, these results prompted us to hypothesize that YC-1 promotes EBP1 p42 binding to the β-catenin/TCF4 complex and subsequently represses the transcriptional activity of the complex in HCC cells. The gene discussed is PA2G4; the disease is hepatocellular carcinoma.